• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Africa pushes for climate finance, adaptation action ahead of COP32
  • Media credibility crucial to success of 2027 polls – GOCOP president
  • NEMA distributes relief materials to Abia windstorm, erosion victims
  • Radda flags off ₦1.4bn Ingawa hospital upgrade
  • LAWMA targets faster waste removal in 60-day plan
  • NAFDAC seizes, destroys ₦100bn worth of unsafe products
  • Jigawa confirms 242 diphtheria cases across 19 LGAs
  • Rotary takes free cancer screening to Plateau community
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    Nigeria’s coffee growers face an uphill road to recognition

    November 21, 2026

    Ogun farmers call for better roads, security, inputs

    November 20, 2026

    Kaduna poultry farmers struggle with feed costs

    November 20, 2026

    Enugu residents call for steps to stabilise onion prices

    November 20, 2026

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026
  • Sci & Tech

    Foreign AI Chatbots could expose patients’ medical data

    November 21, 2026

    GTA VI claims biggest launch in entertainment history

    November 21, 2026

    Expert calls for wider access to digital services in Nigeria

    November 20, 2026

    Rural connectivity key to inclusive digital growth, expert says

    November 20, 2026

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026
  • Health

    Radda flags off ₦1.4bn Ingawa hospital upgrade

    November 21, 2026

    LAWMA targets faster waste removal in 60-day plan

    November 21, 2026

    NAFDAC seizes, destroys ₦100bn worth of unsafe products

    November 21, 2026

    Jigawa confirms 242 diphtheria cases across 19 LGAs

    November 21, 2026

    Rotary takes free cancer screening to Plateau community

    November 21, 2026
  • Environment

    Africa pushes for climate finance, adaptation action ahead of COP32

    November 21, 2026

    NEMA distributes relief materials to Abia windstorm, erosion victims

    November 21, 2026

    Bayelsa boat accident renews concerns over waterway safety

    November 21, 2026

    Ghana warns of El Niño-linked health risks as harmattan intensifies

    November 20, 2026

    Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence

    November 20, 2026
  • Hausa News

    Foundation unveils public sector reform playbook

    November 12, 2026

    Tinubu asks Reps to approve N10.79tn external borrowing for 2026 budget

    November 11, 2026

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    Africa pushes for climate finance, adaptation action ahead of COP32

    November 21, 2026

    Media credibility crucial to success of 2027 polls – GOCOP president

    November 21, 2026

    NEMA distributes relief materials to Abia windstorm, erosion victims

    November 21, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Africa pushes for climate finance, adaptation action ahead of COP32

    November 21, 2026

    Media credibility crucial to success of 2027 polls – GOCOP president

    November 21, 2026

    NEMA distributes relief materials to Abia windstorm, erosion victims

    November 21, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»General News»COVID-19: WHO admits small fraction of people may have allergic reaction to vaccines
General News

COVID-19: WHO admits small fraction of people may have allergic reaction to vaccines

Abdallah el-KurebeBy Abdallah el-KurebeMarch 16, 2021No Comments3 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email

The World Health Organisation (WHO) says the agency is aware that a small fraction of people – around one person in every one million people vaccinated— may have severe allergic reaction to the COVID-19 vaccine, known as anaphylaxis.

WHO, in a statement posted on its website on Tuesday, stated that just like the way people react to other vaccines or drugs, they could also react to COVID-19 vaccine.

The organisation stated that “some people could react to the vaccine, especially those with history of anaphylaxis to one of the vaccine constituents which may have higher risk of reaction following COVID-19 vaccination.

“Similarly, if the person provides a history of anaphylaxis with a previous dose of the same vaccine, he or she should be advised not to take the vaccine.’’

The UN health agency made the clarification while reacting to a story published by The Observer Newspaper with the title: “Allergic Person Advised not to take COVID-19 vaccination”.

According to the WHO statement, all vaccination sites should have a medical doctor or clinical officer with the necessary kit to address such reactions or any other adverse event following vaccination to manage allergy.

“WHO recommends that before the first dose, clients should inform the vaccinating team about any allergic reaction they may have had in the past.

“This is a precautionary measure. The healthcare providers will then assess the patient’s medical history to determine if he or she is at risk of severe allergic reaction to a COVID-19 vaccine.

“All immunisation providers are trained to recognise severe allergic reactions and are knowledgeable about the practical steps needed to treat them.

“We encourage all those who are vaccinated to remain at the vaccination site for 30 minutes for observation.’’

During the on-going COVID-19 rollout, WHO is working closely with the Ministry of Health to detect and immediately respond to any serious side effects that may occur within 30 minutes of vaccination and beyond the 30 minutes when the person goes home.

In addition, it stated that the same article reported that some European countries had suspended the rollout of the AstraZeneca vaccine based on reports of rare blood coagulation disorders in a few people.

“WHO is aware that as a precautionary measure, a few countries in the European Union have suspended the use of a specific batch as a precaution, while full investigation is undertaken.

“It is important to note that the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee position is that the vaccine’s benefits continue to outweigh its risks.

“The committee says the vaccine can continue to be administered while investigation of cases of thromboembolic events is ongoing.”

“As soon as WHO gains full understanding of events surrounding the suspension of the AstraZeneca vaccine in those countries, the findings and any changes to current recommendations will be immediately communicated to the public,” it added.

The world body also noted that vaccinations against COVID-19 would not reduce other medical conditions or deaths from other causes.

It stated that “they will continue to occur, including after vaccination but they are not related to the vaccines.”

Meanwhile, around 14.5 million doses of the AstraZeneca COVID-19 vaccine produced by Serum Institute of India have been delivered to 23 African countries under the COVAX initiative as of March 12.

Nearly 600,000 doses of the COVAX-funded AstraZeneca vaccine had been administered.

AstraZeneca vaccine COVID-19 European countries European Medicines Agency’s Pharmacovigilance vaccines allergic reactions WHO
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Abdallah el-Kurebe
  • Website
  • Facebook
  • Twitter
  • LinkedIn

Related Posts

Africa pushes for climate finance, adaptation action ahead of COP32

November 21, 2026

Media credibility crucial to success of 2027 polls – GOCOP president

November 21, 2026

NEMA distributes relief materials to Abia windstorm, erosion victims

November 21, 2026

Leave A Reply Cancel Reply

Africa pushes for climate finance, adaptation action ahead of COP32

November 21, 2026

Media credibility crucial to success of 2027 polls – GOCOP president

November 21, 2026

NEMA distributes relief materials to Abia windstorm, erosion victims

November 21, 2026

Radda flags off ₦1.4bn Ingawa hospital upgrade

November 21, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.